MEDICURE ANNOUNCES RESULTS OF 2022 AGM
06/20/2022
17:00
WINNIPEG, MB, June 20, 2022 /PRNewswire/ – (June 20, 2022) Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the
Healthcare
>
Biotechnology
>
OTC:
MCUJF
Medicure Inc
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Website: http://www.medicure.com
Recent publications about $MCUJF
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICER
05/30/2022
19:00
WINNIPEG, MB, May 30, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021
04/27/2022
20:00
WINNIPEG, MB, April 27, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of
MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST
04/26/2022
13:00
WINNIPEG, MB, April 26, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
MEDICURE ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SUCCESSION PLAN
03/23/2022
17:00
WINNIPEG, MB, March 23, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
Medicure’s Subsidiary – Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy
02/22/2022
09:00
WINNIPEG, MB, Feb. 22, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
Medicure Launches E-Commerce Pharmacy Platform – www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy
02/09/2022
09:53
WINNIPEG, MB, Feb. 9, 2022 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
Medicure Reports Financial Results for Quarter Ended September 30, 2021
11/22/2021
17:00
WINNIPEG, MB, Nov. 22, 2021 /PRNewswire/ - Medicure Inc. (“Medicure” or the “Company“) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization of
Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans
11/22/2021
09:00
WINNIPEG, MB, Nov. 22, 2021 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a company focused on the development and commercialization
Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint
11/04/2021
17:00
WINNIPEG, MB, Nov. 4, 2021 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV: MPH) (OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce
SOTD Membership
Customer Service
Privacy Notice | Terms of Use | Sitemap
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.
Copyright © 2022 stocksoftheday.com. Stocks of the Day does not provide investment advice. All rights reserved.